Literature DB >> 25764009

Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation.

Tatsiana Suvorava1, Nadine Nagy1, Stephanie Pick1, Oliver Lieven2, Ulrich Rüther2, Vu Thao-Vi Dao1, Jens W Fischer1, Martina Weber3, Georg Kojda1.   

Abstract

AIMS: Vascular oxidative stress generated by endothelial NO synthase (eNOS) was observed in experimental and clinical cardiovascular disease, but its relative importance for vascular pathologies is unclear. We investigated the impact of eNOS-dependent vascular oxidative stress on endothelial function and on neointimal hyperplasia.
RESULTS: A dimer-destabilized mutant of bovine eNOS where cysteine 101 was replaced by alanine was cloned and introduced into an eNOS-deficient mouse strain (eNOS-KO) in an endothelial-specific manner. Destabilization of mutant eNOS in cells and eNOS-KO was confirmed by the reduced dimer/monomer ratio. Purified mutant eNOS and transfected cells generated less citrulline and NO, respectively, while superoxide generation was enhanced. In eNOS-KO, introduction of mutant eNOS caused a 2.3-3.7-fold increase in superoxide and peroxynitrite formation in the aorta and myocardium. This was completely blunted by an NOS inhibitor. Nevertheless, expression of mutant eNOS in eNOS-KO completely restored maximal aortic endothelium-dependent relaxation to acetylcholine. Neointimal hyperplasia induced by carotid binding was much larger in eNOS-KO than in mutant eNOS-KO and C57BL/6, while the latter strains showed comparable hyperplasia. Likewise, vascular remodeling was blunted in eNOS-KO only. INNOVATION: Our results provide the first in vivo evidence that eNOS-dependent oxidative stress is unlikely to be an initial cause of impaired endothelium-dependent vasodilation and/or a pathologic factor promoting intimal hyperplasia. These findings highlight the importance of other sources of vascular oxidative stress in cardiovascular disease.
CONCLUSION: eNOS-dependent oxidative stress is unlikely to induce functional vascular damage as long as concomitant generation of NO is preserved. This underlines the importance of current and new therapeutic strategies in improving endothelial NO generation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25764009      PMCID: PMC4580305          DOI: 10.1089/ars.2014.6059

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  61 in total

Review 1.  Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications.

Authors:  David G Harrison; Wei Chen; Sergey Dikalov; Li Li
Journal:  Adv Pharmacol       Date:  2010

2.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

3.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Authors:  Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

4.  Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice.

Authors:  Ciprian B Anea; Bo Cheng; Shruti Sharma; Sanjiv Kumar; R William Caldwell; Lin Yao; M Irfan Ali; Ana M Merloiu; David W Stepp; Stephen M Black; David J R Fulton; R Daniel Rudic
Journal:  Circ Res       Date:  2012-08-20       Impact factor: 17.367

5.  Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase.

Authors:  B Heinzel; M John; P Klatt; E Böhme; B Mayer
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

6.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

7.  Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process.

Authors:  Y Xia; A L Tsai; V Berka; J L Zweier
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

Review 8.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

9.  Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.

Authors:  Colin Cunnington; Tim Van Assche; Cheerag Shirodaria; Ilias Kylintireas; Alistair C Lindsay; Justin M Lee; Charalambos Antoniades; Marios Margaritis; Regent Lee; Ruha Cerrato; Mark J Crabtree; Jane M Francis; Rana Sayeed; Chandi Ratnatunga; Ravi Pillai; Robin P Choudhury; Stefan Neubauer; Keith M Channon
Journal:  Circulation       Date:  2012-02-07       Impact factor: 29.690

Review 10.  Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.

Authors:  Dong Hoon Kang; Sang Won Kang
Journal:  Biomol Ther (Seoul)       Date:  2013-03       Impact factor: 4.634

View more
  5 in total

1.  FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway.

Authors:  Yumei Li; Jiangnan Huang; Zhiyuan Jiang; Yang Jiao; Hui Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection.

Authors:  Ralf Erkens; Tatsiana Suvorava; Thomas R Sutton; Bernadette O Fernandez; Monika Mikus-Lelinska; Frederik Barbarino; Ulrich Flögel; Malte Kelm; Martin Feelisch; Miriam M Cortese-Krott
Journal:  Oxid Med Cell Longev       Date:  2018-04-30       Impact factor: 6.543

3.  Caloric restriction reverses left ventricular hypertrophy through the regulation of cardiac iron homeostasis in impaired leptin signaling mice.

Authors:  Hyeong Seok An; Jong Youl Lee; Eun Bee Choi; Eun Ae Jeong; Hyun Joo Shin; Kyung Eun Kim; Kyung-Ah Park; Zhen Jin; Jung Eun Lee; Jin Sin Koh; Woori Kwak; Won-Ho Kim; Gu Seob Roh
Journal:  Sci Rep       Date:  2020-04-28       Impact factor: 4.379

4.  Intralesional Infiltrations of Arteriosclerotic Tissue Cells-Free Filtrate Reproduce Vascular Pathology in Healthy Recipient Rats.

Authors:  Jorge Berlanga-Acosta; Maday Fernández-Mayola; Yssel Mendoza-Marí; Ariana García-Ojalvo; Indira Martinez-Jimenez; Nadia Rodriguez-Rodriguez; Raymond J Playford; Osvaldo Reyes-Acosta; Laura Lopez-Marín; Gerardo Guillén-Nieto
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Vorapaxar stabilizes permeability of the endothelial barrier under cholesterol stimulation via the AKT/JNK and NF‑κB signaling pathways.

Authors:  Jianliang Pang; Peiyang Hu; Junwei Wang; Jinsong Jiang; Jifu Lai
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.